Prescription OxyContin abuse among patients entering addiction treatment. - Wikidata - wikimedia - TriplyDB

Prescription OxyContin abuse among patients entering addiction treatment.

Prescription OxyContin abuse among patients entering addiction treatment.

http://www.wikidata.org/entity/Q37445431

about

Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatment Risk factors for incident nonmedical prescription opioid use and abuse and dependence: results from a longitudinal nationally representative sample.Gender differences in risk factors for aberrant prescription opioid use Strategies to prevent opioid misuse, abuse, and diversion that may also reduce the associated costs.Gender and prescription opioids: findings from the National Survey on Drug Use and Health Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later Age differences in heroin and prescription opioid abuse among enrolees into opioid treatment programs Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial.Oxycodone abuse in New York City: characteristics of intravenous and intranasal users.Prescription drug abuse: epidemiology, regulatory issues, chronic pain management with narcotic analgesics Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine Abuse-deterrent formulations, an evolving technology against the abuse and misuse of opioid analgesics.A Randomized, Double-Blind, Double-Dummy Study to Evaluate the Intranasal Human Abuse Potential and Pharmacokinetics of a Novel Extended-Release Abuse-Deterrent Formulation of Oxycodone Evaluation of ongoing oxycodone abuse among methadone-maintained patients Update on prescription extended-release opioids and appropriate patient selection.Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot study.Physical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the United States.Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population.Prescription opioid aberrant behaviors: a pilot study of sex differences.Toward primary prevention of extra-medical OxyContin® use among young people The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?Clinical strategies for the primary health care professional to minimize prescription opioid abuse.Evolution of opioid risk management and review of the classwide REMS for extended-release/long-acting opioids.Primary care considerations of the pharmacokinetics and clinical use of extended-release opioids in treating patients with chronic noncancer pain.Characterization of prescription opioid abuse in the United States: focus on route of administration.Would legalizing illicit opioids reduce overdose fatalities? Implications from a natural experiment.Comparison of subjective effects of extended-release versus immediate-release oxycodone/acetaminophen tablets in healthy nondependent recreational users of prescription opioids: a randomized trial.Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations.Self-limiting non-medical pharmaceutical opioid use among young people in Sydney, Australia: An exploratory study.RGS9-2 Modulates Responses to Oxycodone in Pain-Free and Chronic Pain States.Turning the tide or riptide? The changing opioid epidemic.Correlation of Subjective Effects with Systemic Opioid Exposure from Fixed-Dose Combinations of Oxycodone/Acetaminophen in Recreational Users of Prescription Drugs.Opioid Treatment Agreements Repurposed-But Who Monitors the Monitors?Validity of self-reported misuse of prescription opioid analgesics.Attractiveness of reformulated OxyContin(R) tablets: assessing comparative preferences and tampering potential.Relative preferences in the abuse of immediate-release versus extended-release opioids in a sample of treatment-seeking opioid abusers.Changes in prevalence of prescription opioid abuse after introduction of an abuse-deterrent opioid formulation.The prescription opioid epidemic: a review of qualitative studies on the progression from initial use to abuse.

P2860

Q28396625-50F9A08F-E993-498C-A523-6D624698A43D Q28743202-9EA84A03-74B4-4173-ADD9-0684BF31A061 Q33613641-6EF7ABD6-BC8B-4273-B9ED-CA17703C5940 Q33761976-9F3DC9AB-4A71-4A7B-8F60-28530C3322C3 Q33932344-BDE814DD-F041-40B3-9823-3C6FE4B1778D Q34057971-41B99A28-17E5-4A10-9856-16C0BA9EBE12 Q34090634-BF2E7D66-9EFD-4D07-A645-94B980AAFF60 Q34859268-7A76BFB5-31D9-48AF-BA98-22CDF275A988 Q35052770-F2C1627D-8531-49D5-AEA8-07C2F1664761 Q35189633-36949122-7328-47AD-BA2E-A1D1DCD451C1 Q35873865-EA564A70-AEC4-4842-9FA8-01887958B4F7 Q35893940-7FD67AF7-D9A1-4BC2-B0B6-741F738E2940 Q36394777-16321205-D721-429F-9358-AAE1C88EF616 Q36549049-BD774786-BC7C-461D-AF74-B256AA5B416E Q36972164-1CCB72CF-A0E4-41BA-A2BC-1E8EAC468B4E Q36980798-DDBBFD7B-F2C2-4279-AC28-41ED5A656F35 Q37053718-4FD1E129-47BA-4DB2-802D-B334B51CBC5E Q37098791-295A1AF0-124E-40F5-BE63-F5CF9D3825D1 Q37109399-12881DF6-4579-4CF4-876E-5C4609562D48 Q37116421-B06F866B-1831-48D9-BA6E-4BB1764E9878 Q37408174-5F948F83-6826-4B8E-8642-D62320EFB37C Q37592351-20C60789-AC53-436B-8FC4-157F0241C432 Q37982103-039E033D-66D4-4A06-92FE-1CEF1B5DD2A9 Q38018218-904E15F7-3CAD-46CD-8EBF-E650ECBB25FB Q38073083-AB74E805-5262-4A23-A039-929F3BEB191E Q38079923-82E04391-0D59-4AFB-B39C-69A2D28E92FD Q38106987-0666BD18-DE91-434C-8C93-2144D8E93F61 Q38181184-8D36C460-EC27-480C-8B39-DD1D830863B5 Q38241632-4EBDC613-6522-413B-8EB6-7E1CBD088E72 Q38632934-C929451E-6EA1-43A7-8FE6-04D98C77D52B Q38895082-A35AFCC9-5711-4407-AECD-DE1DF66BBFD6 Q39027669-16B5ED78-2722-4325-96AD-AE040C401D95 Q39178248-1CA0411E-CF07-45A0-A449-51BB13AA48BF Q40610091-9C399D82-0D6E-45A7-B39A-981AFB399446 Q42025340-D3DC408E-EC15-4034-9F6F-476698A69DD2 Q42999550-D7F3FBDC-5545-4901-8838-C9DBC0A9B5C2 Q44184161-16C001BB-0A07-4853-BFA4-FA475F9E2ECD Q44339897-A04DD7BA-A4F5-4850-BD05-16A738717BDC Q44342495-9B79EDAE-F017-444C-BCB6-1E3B67EDD840 Q47138215-CABFC51B-6660-45A7-9FC9-5D5D14369165

P2860

Prescription OxyContin abuse among patients entering addiction treatment.

http://www.wikidata.org/entity/Q37445431

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Prescription OxyContin abuse among patients entering addiction treatment.

@en

Prescription OxyContin abuse among patients entering addiction treatment.

@nl

type

label

Prescription OxyContin abuse among patients entering addiction treatment.

@en

Prescription OxyContin abuse among patients entering addiction treatment.

@nl

prefLabel

Prescription OxyContin abuse among patients entering addiction treatment.

@en

Prescription OxyContin abuse among patients entering addiction treatment.

@nl

P1433

Q37445431-1E905032-BF33-4261-809B-5911C58FF5CB

P1476

Q37445431-945692E4-7FBA-454E-9319-6E45EE05A151

P2093

Q37445431-0584C09F-3263-4E64-95F6-988E294A68BD

Q37445431-10A671A4-9E0E-48D1-A7E5-B5D0CEC9688B

Q37445431-5311254E-DBB4-4CE7-8C68-1AEDC1ED62D1

Q37445431-773AC9F0-3847-4C37-AE3B-80F050184C27

Q37445431-D19B9E5B-67FF-4B40-ACD0-D57FC31955E3

Q37445431-DB499810-E95A-43A7-8CD7-9DE1C051E22D

P2860

Q37445431-01DC910F-AFD6-44B6-9766-79D139324EE5

Q37445431-2715C153-3D56-44F8-99B6-19C6E53B2BC3

Q37445431-47D9F6B4-A295-47BD-BC7E-3A6170A201FF

Q37445431-48D197B9-64D8-4BE7-A92C-CE70D27DBF0F

Q37445431-576B45F9-3CFF-4FA0-8200-F6847EF0F717

Q37445431-57C2F138-6D5F-4036-9DF1-5BA8A810CB1C

Q37445431-705068D6-CDFB-477B-9CBE-119C1B24AE40

Q37445431-749ED9EB-6AAF-473B-9C2F-C95E037CAF47

Q37445431-7BB60CD3-E8DB-4217-B47A-0E6569E8953B

Q37445431-A5EE60B1-6016-4191-92EF-6E1843F56869

P304

Q37445431-DD6594FA-D1C6-4B39-963C-930691499B94

P31

Q37445431-D4B3C8FE-6F75-4700-9824-619748793992

P356

Q37445431-793BB191-75BB-41D7-A1FF-7BE4E3B1AA1B

P407

Q37445431-D6FF24DC-2AE0-448D-B817-4622A4C368B4

P433

Q37445431-1E70C4A8-ECD0-48CE-B2C6-A8613F3486F6

P478

Q37445431-547EEFB9-9831-4227-8770-02B859AAB427

P577

Q37445431-2BFEC171-1D2F-4752-A149-CCEF42FBD407

P5875

Q37445431-425435A9-1D1E-4B04-A8C7-4AF5787C5E3D

P698

Q37445431-24732680-A5BF-4C7C-AA49-B951FD91BA4E

P921

Q37445431-773B921A-7206-4484-8C95-AE5C05247BCF

P932

Q37445431-ACF2F380-059D-4865-BBF6-0660E8F11EAE

P356

APPI.AJP.2007.07050252

P1433

American Journal of Psychiatry

P1476

Prescription OxyContin abuse among patients entering addiction treatment.

@en

P2093

A Thomas McLellan

http://www.w3.org/2001/XMLSchema#string

Amy Camilleri

http://www.w3.org/2001/XMLSchema#string

Deni Carise

http://www.w3.org/2001/XMLSchema#string

George E Woody

http://www.w3.org/2001/XMLSchema#string

Karen Leggett Dugosh

http://www.w3.org/2001/XMLSchema#string

Kevin G Lynch

http://www.w3.org/2001/XMLSchema#string

P2860

Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004

Addiction Rare in Patients Treated with Narcotics

Mechanisms of fatal opioid overdose.

Prescription opioid abuse in patients presenting for methadone maintenance treatment.

New data from the Addiction Severity Index. Reliability and validity in three centers.

Can the national addiction treatment infrastructure support the public's demand for quality care?

Identifying United States substance abuse treatment programs: a test in one mid-sized city.

Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases.

The potent perils of a miracle drug.

Responding rationally to recent report of abuse/diversion of Oxycontin.

P304

1750-1756

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1176/APPI.AJP.2007.07050252

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5871338

http://www.w3.org/2001/XMLSchema#string

P698

17974941

http://www.w3.org/2001/XMLSchema#string

P921

P932

2785002

http://www.w3.org/2001/XMLSchema#string